![John Hamill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Hamill
Finanzdirektor/CFO bei
APREA THERAPEUTICS, INC.
Vermögen: 24 115 $ am 30.06.2026
Profil
John P.
Hamill is Chairman at CVie Therapeutics Ltd., Member of The American Institute of Certified Public Accountants, Member of the Pennsylvania Institute of Certified Public Accountants, and Secretary, Chief Financial & Accounting Officer at Aprea Therapeutics, Inc. Former roles include Chief Financial Officer & Senior Vice President at Windtree Therapeutics, Inc. (2020–2023), Vice President-Finance at Trevena, Inc. (2018–2019), Interim Chief Financial Officer at Cellectar Biosciences, Inc. (2017–2018), CEO, CFO, Secretary & Treasurer at Medpace Research, Inc. (2016–2017), Co-President & Chief Financial Officer at Savient Pharmaceuticals, Inc. (2012–2014), Chief Financial Officer & Executive Vice President at inVentiv Health Clinical, Inc., and Principal at Johnson & Johnson and Rhone-Poulenc Pharmaceuticals North America.
Education includes an undergraduate degree from DeSales University, conferred in 1986.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
APREA THERAPEUTICS, INC. 0,24 % | 21.04.2026 | 30 069 ( 0,24 % ) | 24 115 $ | 30.06.2026 |
Aktive Positionen von John Hamill
| Unternehmen | Position | Beginn |
|---|---|---|
| APREA THERAPEUTICS, INC. | Finanzdirektor/CFO | 30.01.2023 |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Pennsylvania Institute of Certified Public Accountants
 Pennsylvania Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates as a statewide professional association for certified public accountants | Corporate Officer/Principal | - |
CVie Therapeutics Ltd.
 CVie Therapeutics Ltd. BiotechnologyHealth Technology Develops and researched drugs | Vorsitzender | - |
Ehemalige bekannte Positionen von John Hamill
| Unternehmen | Position | Ende |
|---|---|---|
| WINDTREE THERAPEUTICS, INC. | Finanzdirektor/CFO | 27.01.2023 |
| TREVENA, INC. | Comptroller/Controller/Auditor | 01.08.2018 |
| CELLECTAR BIOSCIENCES, INC. | Finanzdirektor/CFO | 01.04.2018 |
| NEPHROGENEX INC | Vorstandsvorsitzender | 01.05.2017 |
| SAVIENT PHARMACEUTICALS INC | Finanzdirektor/CFO | 01.01.2014 |
Ausbildung von John Hamill
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
52
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Windtree Therapeutics, Inc.
 Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and drug development services | Commercial Services |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
DeSales University
 DeSales University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medpace Research, Inc.
 Medpace Research, Inc. Medical DistributorsDistribution Services Develops drugs and novel therapies for kidney diseases | Distribution Services |
Pennsylvania Institute of Certified Public Accountants
Pennsylvania Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates as a statewide professional association for certified public accountants | Commercial Services |
Trevena, Inc.
 Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Rhone-Poulenc Pharmaceuticals North America | |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
CVie Therapeutics Ltd.
CVie Therapeutics Ltd. BiotechnologyHealth Technology Develops and researched drugs | Health Technology |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
